1Decisions
1Patient groups
Added benefit by patient group
Decisions, newest first
Each decision lists only the patient groups coded with this disease.
Non-quantifiableHint
Kinder, Jugendliche und Erwachsene ab einem Alter von 2 Monaten mit cholestatischem Pruritus bei Alagille-Syndrom
Active substance
Maralixibat
Appropriate comparator therapy
N/A
Data status: 2026-10-29